BackCalidi Biotherapeutics Overview
Calidi Biotherapeutics Inc - Ordinary Shares - Class A

Calidi Biotherapeutics Discounted Cash Flow

DCF Analysis for CLDI.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.71

Current Fair Value

$0.71
359.4% Upside

Undervalued by 359.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading